Liposomal Pegylated Doxorubicin versus Low-Dose Recombinant Interferon Alfa-2a in the Treatment of Advanced Classic Kaposi's Sarcoma; Retrospective Analysis of Three German Centers

Author： Kreuter Alexander   Rasokat Heinrich   Klouche Mariam   Esser Stefan   Bader Armin   Gambichler Thilo   Altmeyer Peter   Brockmeyer Norbert  

Publisher： Informa Healthcare

ISSN： 0735-7907

Source： Cancer Investigation, Vol.23, Iss.8, 2005-11, pp. : 653-659

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost-effectiveness Analysis of Pegylated-liposomal Doxorubicin and Liposomal Daunorubicin Treatments in Patients with Kaposi's Sarcoma

By Hjortsberg Catharina   Persson Ulf   Lidbrink Elisabet   Bennett Charles  

Acta Oncologica, Vol. 38, Iss. 8, 1999-12 ,pp. : 1063-1067

Informa Healthcare

Access to resources Recommend Favorite

Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL(R)/CAELYX(R)) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma - a study by the EORTC Soft Tissue and Bone Sarcoma Group

By Judson I.   Radford J.A.   Harris M.   Blay J.-Y.   van Hoesel Q.   le Cesne A.   van Oosterom A.T.   Clemons M.J.   Kamby C.   Hermans C.   Whittaker J.   Donato di Paola E.   Verweij J.   Nielsen S.  

European Journal of Cancer, Vol. 37, Iss. 7, 2001-05 ,pp. : 870-877

Elsevier

Access to resources Recommend Favorite

Long-term chemotherapy of HIV-associated Kaposi's sarcoma with liposomal doxorubicin

By Hengge U.R.   Esser S.   Rudel H.-P.   Goos M.  

European Journal of Cancer, Vol. 37, Iss. 7, 2001-05 ,pp. : 878-883

Elsevier

Access to resources Recommend Favorite

A Randomized Phase 2 Trial of Bevacizumab with or without Daily Low-Dose Interferon Alfa-2b in Metastatic Malignant Melanoma

By Varker Kimberly   Biber Jennifer   Kefauver Cheryl   Jensen Rhonda   Lehman Amy   Young Donn   Wu Haifeng   Lesinski Gregory   Kendra Kari   Chen Helen   Walker Michael   Carson III William  

Annals of Surgical Oncology, Vol. 14, Iss. 8, 2007-08 ,pp. : 2367-2376

Springer Publishing Company

Access to resources Recommend Favorite

Phase II trial of pegylated-liposomal doxorubicin in the treatment of locally advanced unresectable or metastatic transitional cell carcinoma of the urothelial tract

By Winquist E.   Ernst D.S.   Jonker D.   Moore M.J.   Segal R.   Lockwood G.   Rodgers A.  

European Journal of Cancer, Vol. 39, Iss. 13, 2003-09 ,pp. : 1866-1871

Elsevier

Access to resources Recommend Favorite